Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Type I or II Diabetes Mellitus
Age: Adult
Dose: Subcutaneous – Dosage based on blood glucose measurements
Frequency: once daily
Note: Administer with evening meal or at bedtime. Adjust to achieve appropriate glucose control. Look for consistent pattern in blood sugars for greater than 3 days.
Indication: Type I or II Diabetes Mellitus
Age: Adult
Dose: Subcutaneous – Dosage based on blood glucose measurements
Frequency: twice daily
Note: Administer with morning meal and either with evening meal, at bedtime, or 12 hours after the morning dose. Adjust to achieve appropriate glucose control. Look for consistent pattern in blood sugars for greater than 3 days.

Child Dose

Clinical InformationAdministration Information
Indication: Type 1 Diabetes Mellitus
Age: less than 2 years
Dose: Subcutaneous – dose not established
Note: Safety and efficacy not established
Indication: Type 1 Diabetes Mellitus
Age: greater than 2 years
Dose: Subcutaneous – Approximately one-third of the total daily insulin requirements
Note: Subcutaneous; rapid-acting or short-acting, premeal insulin should be used to satisfy the remainder of the daily insulin requirements; usual daily maintenance range in adolescents is less than 1.2 units/kg/day during growth spurts

Renal Dose

Clinical InformationAdministration Information
Condition: Renal impairment
Dose: Renal Dose – Dose adjustments may be needed
Note: Renal impairment: Dose adjustments may be needed.
Administration
  • Can be taken with or without food
  • Give at bedtime if once daily
Side Effect

Drug Interaction

Drug NameRisk Factors
Beta-blockers (Propranolol, Metoprolol, Atenolol, Bisoprolol, Carvedilol, Nadolol, Timolol, Sotalol)
Possible absence of hypoglycaemic warning symptoms
Thiazide diuretics (Chlorothiazide, Chlorthalidone, Hydrochlorothiazide, Indapamide, Metolazone), corticosteriods, chlorpromazine, tibolone, isoniazid, niacin, some calcium-channel blockers (diltiazem, nifedipine), diazoxide, lithium, thyroid hormones
Increased blood sugar

Disease Interaction

Disease NameRisk Factors
Contraindicated routes
Wrong administration can be dangerous

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Unused (unopened) Insulin Detemir should be stored in the refrigerator between 2° and 8°C. Do not store in the freezer or directly adjacent to the refrigerator cooling element. Do not freeze. Do not use Insulin Detemir if it has been frozen. Unused (unopened) Insulin Detemir can be kept until the expiration date printed on the label if it is stored in a refrigerator. Keep unused Insulin Detemir in the carton so that it stays clean and protected from light.

If refrigeration is not possible, unused (unopened) Insulin Detemir can be kept unrefrigerated at room temperature, below 30°C as long as it is kept as cool as possible and away from direct heat and light. Unrefrigerated Insulin Detemir should be discarded 42 days after it is first kept out of the refrigerator, even if the FlexPen or vial still contains insulin.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.